COVID-19 Pandemic in Women–Rheumatologist’s Perspective

COVID-19 has caused unprecedented challenges to every field. Rheumatic diseases (RD) are more common in women compared with men. Patients with RD are predisposed to infections both because of their disease and immunosuppressive medication. The severity of COVID-19 in women is less as compared with m...

Full description

Bibliographic Details
Main Authors:	Benzeeta Pinto, Rashmi Roongta
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2020-09-01
Series:	Indian Journal of Cardiovascular Disease in Women
Subjects:	covid 19 in women rheumatic diseases immunosuppressants
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1717045

id	doaj-859d8f95defc472aa37c7824672b2ebb
record_format	Article
spelling	doaj-859d8f95defc472aa37c7824672b2ebb2020-12-02T18:50:27ZengThieme Medical and Scientific Publishers Pvt. Ltd.Indian Journal of Cardiovascular Disease in Women2455-78542020-09-0150325025510.1055/s-0040-1717045COVID-19 Pandemic in Women–Rheumatologist’s PerspectiveBenzeeta Pinto0Rashmi Roongta1Department of Clinical Immunology and Rheumatology, John’s Medical College, Bengaluru, IndiaDepartment of Rheumatology, Institute of Post Graduate Medical Education and Research, Kolkata, IndiaCOVID-19 has caused unprecedented challenges to every field. Rheumatic diseases (RD) are more common in women compared with men. Patients with RD are predisposed to infections both because of their disease and immunosuppressive medication. The severity of COVID-19 in women is less as compared with men among the general population. It is not known if the risk is higher in women with RD compared with other women. Currently, published data of COVID-19 in RD suggests similar or mildly increased risk in patients with RD but sex disaggregated data is not available. In this article, we review the current evidence of COVID-19 in RD with an emphasis on women.http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1717045covid 19 in womenrheumatic diseasesimmunosuppressants
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Benzeeta Pinto Rashmi Roongta
spellingShingle	Benzeeta Pinto Rashmi Roongta COVID-19 Pandemic in Women–Rheumatologist’s Perspective Indian Journal of Cardiovascular Disease in Women covid 19 in women rheumatic diseases immunosuppressants
author_facet	Benzeeta Pinto Rashmi Roongta
author_sort	Benzeeta Pinto
title	COVID-19 Pandemic in Women–Rheumatologist’s Perspective
title_short	COVID-19 Pandemic in Women–Rheumatologist’s Perspective
title_full	COVID-19 Pandemic in Women–Rheumatologist’s Perspective
title_fullStr	COVID-19 Pandemic in Women–Rheumatologist’s Perspective
title_full_unstemmed	COVID-19 Pandemic in Women–Rheumatologist’s Perspective
title_sort	covid-19 pandemic in women–rheumatologist’s perspective
publisher	Thieme Medical and Scientific Publishers Pvt. Ltd.
series	Indian Journal of Cardiovascular Disease in Women
issn	2455-7854
publishDate	2020-09-01
description	COVID-19 has caused unprecedented challenges to every field. Rheumatic diseases (RD) are more common in women compared with men. Patients with RD are predisposed to infections both because of their disease and immunosuppressive medication. The severity of COVID-19 in women is less as compared with men among the general population. It is not known if the risk is higher in women with RD compared with other women. Currently, published data of COVID-19 in RD suggests similar or mildly increased risk in patients with RD but sex disaggregated data is not available. In this article, we review the current evidence of COVID-19 in RD with an emphasis on women.
topic	covid 19 in women rheumatic diseases immunosuppressants
url	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1717045
work_keys_str_mv	AT benzeetapinto covid19pandemicinwomenrheumatologistsperspective AT rashmiroongta covid19pandemicinwomenrheumatologistsperspective
_version_	1724402985820225536

COVID-19 Pandemic in Women–Rheumatologist’s Perspective

Similar Items